![Jeffrey Friedman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Friedman
Consultant / Advisor at
Kallyope, Inc.
Profile
Jeffrey Friedman is the founder of Envoy Therapeutics, Inc., founded in 2009.
Dr. Friedman is the founder of Redpin Therapeutics, Inc., founded in 2017.
Dr. Friedman is also the founder of Millennium Pharmaceuticals, Inc...
Dr. Friedman is currently a member of the Scientific Advisory Board at Kallyope, Inc. Dr. Friedman was a member of the Scientific Advisory Board at Amylin Pharmaceuticals, Inc. Dr. Friedman was a Venture Partner at Catalio Capital Management LP.
Dr. Friedman completed undergraduate studies at Rensselaer Polytechnic Institute.
Dr. Friedman earned a doctorate from The Rockefeller University.
Dr. Friedman earned a doctorate from Albany Medical College.
Jeffrey Friedman active positions
| Companies | Position | Start |
|---|---|---|
Kallyope, Inc.
 Kallyope, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of migraine and neurological problems | Consultant / Advisor | - |
Former positions of Jeffrey Friedman
| Companies | Position | End |
|---|---|---|
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Private Equity Investor | - |
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders | Founder | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Founder | - |
Envoy Therapeutics, Inc.
 Envoy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treatment of neurological and psychiatric diseases | Founder | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Consultant / Advisor | - |
Training of Jeffrey Friedman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albany Medical College
 Albany Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Envoy Therapeutics, Inc.
Envoy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treatment of neurological and psychiatric diseases | Health Technology |
Kallyope, Inc.
Kallyope, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of migraine and neurological problems | Health Technology |
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders | Commercial Services |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Finance |
- Stock Market
- Insiders
- Jeffrey Friedman
